Endpoints News 07.24.20 Turning cancer into a curable disease: Immunotherapy expert John Connolly picks up the reins as the new CSO of Sean Parker’s cancer institute Read
Multiple Myeloma Hub 07.09.20 How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease Read
Genetic Engineering and Biotechnology News 07.01.20 Leaps in Innovation in Cancer Immunology: An Expert Panel Discussion Read
Cancer Therapy Advisor 06.08.20 Early-Memory T-Cell Population May Predict CAR-T Efficacy in Several Hematological Malignancies Read
The ASCO Post 05.10.20 Parker Institute for Cancer Immunotherapy Appoints Frederic Pla, PhD, as Chief Operating Officer Read
ASH Clinical News 05.01.20 CPRIT Awards $19.6 Million to MD Anderson, Sidney Kimmel Establishes Philadelphia T-cell Lymphoma/Leukemia Initiative, and more Read
Endpoints News 04.09.20 Frederic Pla enlisted as COO at the Parker Institute; Former Alkermes exec named CMO at Seres Therapeutics Read
The ASCO Post 03.25.20 The Parker Institute for Cancer Immunotherapy Awards $2.75 Million to Support Six Early-Career Researchers Read